• Takeda’s setback with its diabetes drug alogliptin after an FDA thumbs down has hurt the company’s shares. [Reuters]

• Roche axes Accutane, drug pulled. [Reuters]

• Erbitux for lung cancer not worth the $80,000 price tag. [Bloomberg]

• Teva and Antares get FDA thumbs up for needle-free injection device. [BizJournals]

• Paladin Labs picks up some of Wyeth’s drug programs. [BusinessWeek]

• Alizyme heading to the Graveyard? [FierceBiotech]

• Roche to PhRMA: we’re out! [NJ]

• Finally, Abbott has to pay $1.67 billion to J&J’s Centocor unit for using its invention to make arthritis drug Humira, a federal jury said. The price tag puts the decision as the largest patent verdict in U.S. history. Wow!! [Bloomberg]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts